Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1059)
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
6,871
Price
$30.04
Total Value
$206.40K
Shares Held After
1,518,219
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
877
Price
$28.70
Total Value
$25.17K
Shares Held After
1,525,090
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
342
Price
$27.57
Total Value
$9.43K
Shares Held After
1,525,967
% of Holdings
0.0%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
5,548
Price
$5.96
Total Value
$33.07K
Shares Held After
313,071
% of Holdings
1.7%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
3,000
Price
$87.00
Total Value
$261.00K
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
305,741
Price
$0.70
Total Value
$214.02K
Shares Held After
1,273,008
% of Holdings
19.4%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$42.14
Total Value
$1.05M
Shares Held After
1,323,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
25,012
Price
$0.71
Total Value
$17.76K
Shares Held After
418,813
% of Holdings
5.6%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
351,514
Price
$0.71
Total Value
$249.57K
Shares Held After
5,885,968
% of Holdings
5.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
600
Price
$79.28
Total Value
$47.57K
Shares Held After
105,212
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
200
Price
$78.00
Total Value
$15.60K
Shares Held After
105,812
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,900
Price
$79.31
Total Value
$150.69K
Shares Held After
105,212
% of Holdings
1.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
840
Price
$78.23
Total Value
$65.71K
Shares Held After
107,112
% of Holdings
0.8%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
20,000
Price
$25.00
Total Value
$500.00K
Shares Held After
169,669
% of Holdings
10.5%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
25,000
Price
$25.10
Total Value
$627.50K
Shares Held After
189,669
% of Holdings
11.6%
BIO-TECHNE Corp (TECH)
Herr Amy E. — Director
Shares
6,636
Price
$48.28
Total Value
$320.39K
Shares Held After
200
% of Holdings
97.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
3,205
Price
$29.20
Total Value
$93.59K
Shares Held After
1,526,309
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
1,582
Price
$28.56
Total Value
$45.18K
Shares Held After
1,529,514
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
29,624
Price
$27.48
Total Value
$814.07K
Shares Held After
1,531,096
% of Holdings
1.9%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
5,130
Price
$100.00
Total Value
$513.00K
Shares Held After
12,695
% of Holdings
28.8%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
6,000
Price
$100.00
Total Value
$600.00K
Shares Held After
0
% of Holdings
100.0%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
4,358,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,076
Price
$67.35
Total Value
$341.85K
Shares Held After
4,359,397
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,974
Price
$66.65
Total Value
$931.37K
Shares Held After
4,364,473
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
555,686
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,077
Price
$67.35
Total Value
$341.91K
Shares Held After
556,636
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,973
Price
$66.65
Total Value
$931.31K
Shares Held After
561,713
% of Holdings
2.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Soteropoulos Paula — Director
Shares
599
Price
$85.47
Total Value
$51.20K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
5,018
Price
$40.31
Total Value
$202.26K
Shares Held After
6,432,715
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$571.66
Total Value
$297.27K
Shares Held After
40,513
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$570.22
Total Value
$282.26K
Shares Held After
41,033
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$569.61
Total Value
$60.38K
Shares Held After
41,528
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.16
Total Value
$204.54K
Shares Held After
41,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$567.21
Total Value
$180.94K
Shares Held After
41,994
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
705
Price
$565.99
Total Value
$399.02K
Shares Held After
42,313
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,983
Price
$564.77
Total Value
$1.12M
Shares Held After
43,018
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,864
Price
$564.00
Total Value
$1.05M
Shares Held After
45,001
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$563.06
Total Value
$1.14M
Shares Held After
46,865
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,126
Price
$562.08
Total Value
$632.91K
Shares Held After
48,887
% of Holdings
2.3%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
15,003
Price
$38.30
Total Value
$574.61K
Shares Held After
14,769
% of Holdings
50.4%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
55,000
Price
$38.38
Total Value
$2.11M
Shares Held After
14,769
% of Holdings
78.8%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
134,985
% of Holdings
6.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
19,269
Price
$75.35
Total Value
$1.45M
Shares Held After
88,606
% of Holdings
17.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
24,814
Price
$74.76
Total Value
$1.86M
Shares Held After
107,875
% of Holdings
18.7%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
33,513
Price
$73.72
Total Value
$2.47M
Shares Held After
132,689
% of Holdings
20.2%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,404
Price
$72.57
Total Value
$174.46K
Shares Held After
166,202
% of Holdings
1.4%
Showing 801–850 of 1059 transactions (page 17 of 22)